Skip to main content
. 2017 Dec 15;15(2):2109–2119. doi: 10.3892/etm.2017.5641

Table I.

PCR conditions, primers and restrict enzyme used in the present study.

Gene rs# PCR condition Primer sequence (5′-3′) R/E
VEGF −2578C>A rs699947 94°C 5 min 35 cycles F: GGATGGGGCTGACTAGGTAAG AvaII
94°C 30 sec R: AGCCCCCTTTTCCTCCAAC
−62°C 30 sec
−72°C 30 sec
  72°C 7 min
VEGF −1154G>A rs1570360   94°C 5 min 38 cycles F: CGCGTGTCTCTGGACAGAGTTTCC MnlI
  94°C 30 sec R: CGGGGACAGGCGAGCTTCAG
−59°C 40 sec
−72°C 30 sec
72°C 5 min
VEGF −634C>G rs2010963   94°C 5 min 40 cycles F: CAGGTCACTCACTTTGCCCCGGTC AvaII
  94°C 30 sec R: GCTTGCCATTCCCCACTTGAATCG
−63°C 35 sec
−72°C 30 sec
  72°C 7 min
VEGF 936C>T rs3025039   94°C 5 min 35 cycles F: AAGGAAGAGGAGACTCTGCGCAGAGC NlaIII
  94°C 30 sec R: TAAATGTATGTATGTGGGTGGGTGTGTCTACAGG
−68°C 1 min
−72°C 30 sec
  72°C 7 min

PCR, polymerase chain reaction; rs#, RefSNP(rs) number; R/E, restriction enzyme; VEGF, vascular endothelial growth factor; F, forward primer; R, reverse primer.